Invokana Kidney Damage
Ohio Invokana Kidney Damage Lawyers
There is growing concern that a popular medication prescribed for Type II diabetes may cause ketoacidosis and kidney damages. If you or a loved one has suffered injury as a result of the use of Invokana, our legal team may be able to help.
On December 4, 2015, the U.S. Food and Drug Administration (“FDA”) issued a safety announcement concerning a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (“SGLT2”) inhibitors. The announcement warned of the risks of too much acid in the blood and of serious urinary tract infections, both of which can result in serious injuries and hospitalization.
Invokana (canagliflozin) is a SGLT2 class drug that is designed to control blood sugar levels in people diagnosed with type 2 diabetes. It works by helping the kidneys removed excess sugar from the body through urination.
What is the problem with Invokana?
According to the FDA, dozens of people have been hospitalized for ketoacidosis after ingesting SGLT2 class drugs. Ketoacidosis is serious condition in which the body produces high levels of blood acids called ketones. Symptoms of ketoacidosis include abdominal pain, breathing difficulties, nausea, vomiting, and tiredness.
More About Dangerous Drugs
How can I get more information?
RECENT BLOG POSTS FOR DANGEROUS DRUGS
Vaping Increases Severity of COVID-19 Symptoms
The link between COVID-19 and vaping is becoming more apparent as new research emerges. Evidence shows that the virus may have an easier time infecting the lungs of smokers and vapers. According to a recent article in the New York Times, smoking appears to alter the...
Vaping Damages The Heart Like Regular Cigarettes New Study Shows
A recent report in the Journal of the American Heart Association shows that vaping damages the heart just as bad as traditional cigarettes. E-cigarettes or vaping was once considered a safer alternative to smoking, but continuing studies are debunking this claim....
E-Cigarette Companies Asking for An Extension from the FDA
Due to the recent coronavirus pandemic, e-cigarette makers are looking for an extension on their Food & Drug Administration (FDA) applications. A deadline of May 12, 2020 was previously set as a result of a lawsuit filed by the American Academy of Pediatrics. The...
FDA Proposes Recall of Zantac
The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...
Vaping and Smoking May Increase Your COVID-19 Risks
As the entire world struggles with the new realities of the coronavirus pandemic, much of the focus has been on higher-risk individuals contracting the virus. Higher risk individuals include the elderly and people with compromised immune systems. There is now...
Vaping Deaths and Lung Injuries Continue to Rise
Deaths and Lung Injuries Continue to Rise From E-Cigarette and Vaping Use As of February 18, 2020, 68 deaths have been confirmed in 29 states due to the use of vaping products. Additionally, a total of 2,807 hospitalized e-cigarette, or vaping, product use-associated...